Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-10

Clinical Trial Update: Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia

View source ↗

Summary

An ongoing clinical trial investigates how aspirin metabolism relates to markers of metabolic dysfunction in pregnant people at risk for preeclampsia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: University of Tennessee Graduate School of Medicine | Conditions: Preeclampsia, Preeclampsia (PE) | Status: RECRUITING